Evidence map›Paper›PMID 24834413›Full record

ReviewCardiovascular diagnosis and therapy2014

Assessing the end-organ in peripheral arterial occlusive disease-from contrast-enhanced ultrasound to blood-oxygen-level-dependent MR imaging.

Markus Aschwanden, Sasan Partovi, Bjoern Jacobi, Nathan Fergus, Anja-Carina Schulte, Mark R Robbin, Deniz Bilecen, Daniel Staub

Open access · greenAbstract readReview
In one paragraph

Review in Cardiovascular diagnosis and therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Markus Aschwanden1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Sasan Partovi1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Bjoern Jacobi1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Nathan Fergus1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Anja-Carina Schulte1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Mark R Robbin1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Deniz Bilecen1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Daniel Staub1 University Hospital Basel, Department of Angiology, Basel, Switzerland ; 2 University Hospitals Case Medical Center, Case Western Reserve University, Department of Radiology, Cleveland, Ohio, USA ; 3 University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany ; 4 University Hospital Bruderholz, Department of Radiology, Bruderholz, Switzerland.
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral arterial occlusive disease (PAOD) is a result of atherosclerotic disease which is currently the leading cause of morbidity and mortality in the western world. Patients with PAOD may present with intermittent claudication or symptoms related to critical limb ischemia. PAOD is associated with increased mortality rates. Stenoses and occlusions are usually detected by macrovascular imaging, including ultrasound and cross-sectional methods. From a pathophysiological view these stenoses and occlusions are affecting the microperfusion in the functional end-organs, such as the skin and skeletal muscle. In the clinical arena new imaging technologies enable the evaluation of the microvasculature. Two technologies currently under investigation for this purpose on the end-organ level in PAOD patients are contrast-enhanced ultrasound (CEUS) and blood-oxygen-level-dependent (BOLD) MR imaging (MRI). The following article is providing an overview about these evolving techniques with a specific focus on skeletal muscle microvasculature imaging in PAOD patients.

Indexed as

Duplex ultrasonographymagnetic resonance imagingmicrobubblesperipheral arterial disease

Identifiers

PMID24834413
PMCPMC3996233
OpenAlexW2267987837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.